Suspending the reception of volunteers for clinical trials of the inactive "Corona" vaccine until Saturday ... and returning the pre-registration requirement
The Department of Health Abu Dhabi announced the suspension of receiving volunteers wishing to participate in the first clinical trial in the world for the third phase of the inactivated virus (Covid-19) vaccine, which was developed by the company "Synopharma CNBG", in each of the two clinics of Abu Dhabi National Center For "ADNEC" exhibitions and Al-Qarayen Health Center, in the Emirate of Sharjah, until next Saturday, and work will resume on Sunday according to a different working mechanism that requires prior registration to obtain an appointment.
In detail, the department said: “Due to the increasing demand of volunteers to participate in clinical trials of the third phase of the inactive Covid-19 vaccine, the reception of new applications at the field clinic specialized in" Covid 19 "vaccine trials in ADNEC centers, and health clues, has been stopped, as of today. Thursday until next Saturday, August 15, "noting that the operations in both centers will resume on Sunday, August 16, provided that the current volunteers will be received within the specified daily dates, and more volunteers can participate in the experiments by registering on the website only.
The department asked volunteers wishing to participate in the experiments to visit 4humanity.ae to provide the required details and their contact information to those in charge of this initiative, noting that participation in the experiments is available to individuals from 18 to 60 years of age of all races and nationalities after conducting the necessary medical examinations. .
The world's first clinical trials for the third phase of the inactive Covid-19 vaccine, underway in the UAE, have achieved a new achievement with 15,000 volunteers from 107 nationalities receiving a dose of the vaccine in less than a month. These trials are the fruit of cooperation between the G42 Healthcare Company. ", Based in Abu Dhabi, which plays a leading role in the battle against the Covid-19 pandemic, and" Synopharma CNBG ", the sixth largest producer of vaccines in the world, and experiments are conducted under close supervision and follow-up by the Abu Dhabi Health Department, and specialists from the company Abu Dhabi Health Services "SEHA".